Crossmark

Semaglutide Once-Weekly Persistence and Adherence Versus Other GLP-1 RAs in Patients with Type 2 Diabetes in a US Real-World Setting

Published Online: 2021-04-10

Published Print: 2021-05

Authors

Uzoigwe, Chioma https://orcid.org/0000-0002-6853-7117
Liang, Yuanjie

Whitmire, Sarah

Paprocki, Yurek
Funding

Funding for this research was provided by:

Novo Nordisk Inc.
License Information

Text and Data Mining valid from 2021-04-10

Version of Record valid from 2021-04-10
More Information

Article History

Received: 18 December 2020

Accepted: 22 March 2021

First Online: 10 April 2021

Document is current